Heron Therapeutics (HRTX) Q4 2024 Earnings

12NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.15
-0.11
-0.06
-0.02

Details

Expected EPS
-0.037875
Actual EPS
-0.03
Surprise EPS
0.01
Surprise Percent
+20.79%

Description

Heron Therapeutics (HRTX) has reported earnings of -0.03 per share for Q4 2024.

0 Comments

Share your thoughts